Fill & Finish

Fill & Finish

Contract Manufacturing

Information

Wacker Biotech has over 20 years of experience with aseptic filling and lyophilization of a broad range of biopharmaceuticals. The fill & finish suite in Amsterdam can be used for filling of your bulk drug substance produced at Wacker Biotech, but also as stand-alone service offering. The processes used at Wacker Biotech for the manufacturing of our client drug product batches comply with EMA standards and FDA guidelines.
WackerWacker Biotech is “THE MICROBIAL CDMO” – the partner of choice for process transfer and/or development and commercial manufacturing of biopharmaceuticals (proteins, vaccines and live microbial products) using microbial hosts. Wacker Biotech has progressive experience producing vaccines, extending from classic inactivated and live attenuated vaccines to protein-based, polysaccharide and glycoconjugate vaccines. WACKER’s integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for (pre)clinical and commercial supply. WACKER’s outstanding E. coli technologies can significantly increase the bioprocess efficiency and thereby reduce the cost of goods. We produce with manufacturing lines with a capacity of up to 1,500L to flexibly serve our clients, ranging from small biotechnology companies to big pharmaceutical corporates.